Yüklüyor......
Macitentan: An important addition to the treatment of pulmonary arterial hypertension
Macitentan is an orphan drug for the treatment of pulmonary arterial hypertension (PAH). Endothelin-1 (ET-1) plays a critical role of pathophysiology of PAH. Macitentan, a new dual endothelin receptor antagonist, has reportedly improved prognosis of PAH patients by delaying the progression of diseas...
Kaydedildi:
| Yayımlandı: | J Pharmacol Pharmacother |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319253/ https://ncbi.nlm.nih.gov/pubmed/25709357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.149151 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|